147 related articles for article (PubMed ID: 27223828)
1. Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy.
Zhang Z; Wodzak M; Belzile O; Zhou H; Sishc B; Yan H; Stojadinovic S; Mason RP; Brekken RA; Chopra R; Story MD; Timmerman R; Saha D
Radiat Res; 2016 Jun; 185(6):616-22. PubMed ID: 27223828
[TBL] [Abstract][Full Text] [Related]
2. What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature.
Chen HJ; Liang JA; Chen CY; Yu YH; Chien CR
Thorac Cancer; 2017 Mar; 8(2):118-120. PubMed ID: 28102933
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Accuracy of Bioluminescence Image-Guided Stereotactic Body Radiation Therapy of Orthotopic Pancreatic Tumors Using a Small Animal Irradiator.
Rapic S; Samuel T; Lindsay PE; Ansell S; Weersink RA; DaCosta RS
Radiat Res; 2022 Jun; 197(6):626-637. PubMed ID: 35192719
[TBL] [Abstract][Full Text] [Related]
4. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
[TBL] [Abstract][Full Text] [Related]
6. Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
Rossi MM; Peulen HM; Belderbos JS; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):835-43. PubMed ID: 27131084
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
[TBL] [Abstract][Full Text] [Related]
8. Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.
Han C; Sampath S; Schultheisss TE; Wong JYC
Med Dosim; 2017 Summer; 42(2):116-121. PubMed ID: 28433482
[TBL] [Abstract][Full Text] [Related]
9. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Hou Y; Lee S; Agrawal V; Romano J; Baldini EH; Chen AB; Kozono DE; Killoran JH; Wagar M; Hacker FL; Aerts HJ; Lewis JH; Mak RH
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):93-98. PubMed ID: 27709803
[TBL] [Abstract][Full Text] [Related]
10. Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.
Gunter T; Ali I; Matthiesen C; Machiorlatti M; Thompson D; Algan O
J Med Imaging Radiat Oncol; 2014; 58(3):384-91. PubMed ID: 24592817
[TBL] [Abstract][Full Text] [Related]
11. Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.
Rico M; Martínez E; Pellejero S; Bermejo B; Navarrete P; Barrado M; Campo M; Mañeru F; Villafranca E; Aristu J
Clin Transl Oncol; 2016 Oct; 18(10):1011-8. PubMed ID: 26758718
[TBL] [Abstract][Full Text] [Related]
12. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site.
Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S
J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
Du S; Lockamy V; Zhou L; Xue C; LeBlanc J; Glenn S; Shukla G; Yu Y; Dicker AP; Leeper DB; Lu Y; Lu B
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):529-37. PubMed ID: 27681749
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
16. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
[TBL] [Abstract][Full Text] [Related]
17. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance.
Sonke JJ; Rossi M; Wolthaus J; van Herk M; Damen E; Belderbos J
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):567-74. PubMed ID: 19046825
[TBL] [Abstract][Full Text] [Related]
18. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
19. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.
Bissonnette JP; Franks KN; Purdie TG; Moseley DJ; Sonke JJ; Jaffray DA; Dawson LA; Bezjak A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):688-95. PubMed ID: 19395200
[TBL] [Abstract][Full Text] [Related]
20. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
